Georgios S Stamatakos (Georgios Stamatakos)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Early Breast Cancer

Clinical Decision Support

Papillary Thyroid

Top Venues

Journal of personalized medicine

Interface focus

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Eleni Kolokotroni, Daniel Abler, Alokendra Ghosh, Eleftheria Tzamali, James Grogan, Eleni Georgiadi, Philippe Büchler, Ravi Radhakrishnan, Helen Byrne, Vangelis Sakkalis, Katerina Nikiforaki, Ioannis Karatzanis, Nigel J B McFarlane, Djibril Kaba, Feng Dong, Rainer M Bohle, Eckart Meese, Norbert Graf, Georgios S Stamatakos, null null
A Multidisciplinary Hyper-Modeling Scheme in Personalized In Silico Oncology: Coupling Cell Kinetics with Metabolism, Signaling Networks, and Biomechanics as Plug-In Component Models of a Cancer Digital Twin. Journal of personalized medicine 14 (5) (2024)
Eleni Kolokotroni, Daniel Abler, Alokendra Ghosh, Eleftheria Tzamali, James Grogan, Eleni Georgiadi, Philippe Büchler, Ravi Radhakrishnan, Helen Byrne, Vangelis Sakkalis, Katerina Nikiforaki, Ioannis Karatzanis, Nigel J B McFarlane, Djibril Kaba, Feng Dong, Rainer M Bohle, Eckart Meese, Norbert Graf, Georgios S Stamatakos, null null
A Multidisciplinary Hyper-Modeling Scheme in Personalized In Silico Oncology: Coupling Cell Kinetics with Metabolism, Signaling Networks, and Biomechanics as Plug-In Component Models of a Cancer Digital Twin. Journal of personalized medicine 14 (5) (2024)
Eleni Kolokotroni, Daniel Abler, Alokendra Ghosh, Eleftheria Tzamali, James Grogan, Eleni Georgiadi, Philippe Büchler, Ravi Radhakrishnan, Helen Byrne, Vangelis Sakkalis, Katerina Nikiforaki, Ioannis Karatzanis, Nigel J B McFarlane, Djibril Kaba, Feng Dong, Rainer M Bohle, Eckart Meese, Norbert Graf, Georgios S Stamatakos, null null
A Multidisciplinary Hyper-Modeling Scheme in Personalized In Silico Oncology: Coupling Cell Kinetics with Metabolism, Signaling Networks, and Biomechanics as Plug-In Component Models of a Cancer Digital Twin. Journal of personalized medicine 14 (5) (2024)
Ruth Pat-Horenczyk, Lauren Kelada, Eleni Kolokotroni, Georgios S Stamatakos, Rawan Dahabre, Gabriella Bentley, Shlomit Perry, Evangelos C Karademas, Panagiotis Simos, Paula Poikonen-Saksela, Ketti Mazzocco, Berta Sousa, Albino J Oliveira-Maia, Ilan Roziner, null null
Trajectories of Quality of Life among an International Sample of Women during the First Year after the Diagnosis of Early Breast Cancer: A Latent Growth Curve Analysis. Cancers 15 (7) (2023)
Leena Vehmanen, Johanna Mattson, Evangelos C Karademas, Albino J Oliveira-Maia, Berta Sousa, Ruth Pat-Horenczyk, Ketti Mazzocco, Panagiotis G Simos, Fatima Cardoso, Gretta Pettini, Chiara Marzorati, Eleni Kolokotroni, Georgios S Stamatakos, Diana Frasquilho, Paula Poikonen-Saksela
Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer. The breast journal 2022 (2022)
Gretta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, Berta Sousa, Marianna Masiero, Chiara Marzorati, Viviana Enrica Galimberti, Elisabetta Munzone, Johanna Mattson, Leena Vehmanen, Meri Utriainen, Ilan Roziner, Raquel Lemos, Diana Frasquilho, Fatima Cardoso, Albino J Oliveira-Maia, Eleni Kolokotroni, Georgios S Stamatakos, Riikka-Leena Leskelä, Ira Haavisto, Juha Salonen, Robert Richter, Evangelos C Karademas, Paula Poikonen-Saksela, Ketti Mazzocco
Predicting Effective Adaptation to Breast Cancer to Help Women BOUNCE Back: Protocol for a Multicenter Clinical Pilot Study. JMIR research protocols 11 (10) (2022)
Christos A Kyroudis, Dimitra D Dionysiou, Eleni A Kolokotroni, Georgios S Stamatakos
Studying the regression profiles of cervical tumours during radiotherapy treatment using a patient-specific multiscale model. Scientific reports 9 (1) (2019)
Eleftherios Ouzounoglou, Eleni Kolokotroni, Martin Stanulla, Georgios S Stamatakos
A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator. Interface focus 8 (1) (2017)